Repligen (RGEN) Fails to deliver data

Key failure to deliver metrics for Repligen :

• Last SEC data release: 2026-05-29
• Last 15 days FTD volume: NZ$4.38 M
• Last 3 months FTD volume: NZ$22.72 M
• Last 12 months FTD volume: NZ$34.66 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Repligen (RGEN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Repligen (RGEN) - since 2013

Repligen (RGEN) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Pfizer PFE	NZ$63.7 M	NZ$0.15 B	🇺🇸 USA
Thermo Fisher Scientific TMO	NZ$4.05 M	NZ$56.39 M	🇺🇸 USA
General Electric GE	NZ$38.71 M	NZ$0.21 B	🇺🇸 USA
Bristol-Myers Squibb BMY	NZ$5.5 M	NZ$63.96 M	🇺🇸 USA
Sangamo Therapeutics SGMO	NZ$1.45 M	NZ$7.81 M	🇺🇸 USA
Novavax NVAX	NZ$16.14 M	NZ$60.86 M	🇺🇸 USA
Neurocrine Biosciences NBIX	NZ$13.95 M	NZ$26.48 M	🇺🇸 USA
Bio-Techne TECH	NZ$86.01 M	NZ$0.10 B	🇺🇸 USA
BioMarin Pharmaceutical BMRN	NZ$3.79 M	NZ$16.56 M	🇺🇸 USA
Charles River Laboratories CRL	NZ$13.92 M	NZ$0.11 B	🇺🇸 USA